These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 888497)

  • 81. [The study of the effectiveness of 17-alpha-hydroxyprogesterone capronate in the treatment of threatened abortion].
    Kubinyi J; Pilishegyi J
    Orv Hetil; 1969 Mar; 110(12):654-5. PubMed ID: 4889626
    [No Abstract]   [Full Text] [Related]  

  • 82. [Prognostic significance of maternal serum beta1-glycoprotein determination using LC partigen plates in threatened abortion in early pregnancy].
    Eiermann W; Link A
    Arch Gynecol; 1979 Jul; 228(1-4):231-2. PubMed ID: 485320
    [No Abstract]   [Full Text] [Related]  

  • 83. Pregnancy-specific and pregnancy-associated proteins in threatened abortion.
    Bersinger NA; Keller PJ; Naiem A; Fischer M; Schneider H
    Gynecol Endocrinol; 1987 Dec; 1(4):379-84. PubMed ID: 2459901
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Alpha-fetoprotein: a marker for threatened abortion.
    Sande HA; Fagerhol M; Molnar O; Foss OP; Torjesen P
    Int J Gynaecol Obstet; 1978-1979; 16(4):293-5. PubMed ID: 86467
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Prognostic value of echography in threatened abortion].
    Gramellini D; Chiavazza F; Ventura A; Vadora E
    Ateneo Parmense Acta Biomed; 1977; 48(3):259-62. PubMed ID: 588315
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Placental lactogen levels as guide to outcome of threatened abortion.
    Niven PA; Landon J; Chard T
    Br Med J; 1972 Sep; 3(5830):799-801. PubMed ID: 5076253
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Combined maternal serum inhibin A and embryonic/ fetal heart rate for the prediction of pregnancy outcome in a first-trimester threatened abortion.
    Phupong V; Hanprasertpong T
    J Med Assoc Thai; 2011 May; 94(5):529-34. PubMed ID: 21675439
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Differential approach to the treatment of threatened abortion].
    Borisova IuF; Egorova EV; Kifer GI; Povolotskaia LI
    Sov Med; 1977 Sep; (9):100-3. PubMed ID: 563107
    [No Abstract]   [Full Text] [Related]  

  • 89. Therapeutic value of indomethacin in threatened abortion.
    Souka AR; Osman M; Sibaie F; Einen MA
    Prostaglandins; 1980 Mar; 19(3):457-60. PubMed ID: 6992229
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [The hormonal levels in case of abortion during the first trimester (author's transl)].
    Chartier M
    J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3 Pt 2):673-7. PubMed ID: 701750
    [No Abstract]   [Full Text] [Related]  

  • 91. [Diagnostic assessment of normal and risk pregnancies. 1. Comparison of two radioimmunological methods for the determination of human placental lactogen (author's transl)].
    Musch K; Wolf AS; Lauritzen C
    Geburtshilfe Frauenheilkd; 1978 May; 38(5):365-70. PubMed ID: 648860
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Diagnostic and prognostic value of determining the estradiol-17beta level in the serum of women between the 6th and 20th weeks of pregnancy. II. Serum estradiol-17beta level in women with threatened abortion whose pregnancies terminated in labor].
    Pawelczyk L; Głyda A; Pisarski T
    Ginekol Pol; 1986 Oct; 57(10):679-83. PubMed ID: 3817575
    [No Abstract]   [Full Text] [Related]  

  • 93. Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion.
    Genazzani AR; Aubert ML; Casoli M; Fioretti P; Felber JP
    Lancet; 1969 Dec; 2(7635):1385-7. PubMed ID: 4188275
    [No Abstract]   [Full Text] [Related]  

  • 94. [Therapeutics basis of threatened abortions (author's transl)].
    Viala JL
    J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3 Pt 2):678-82. PubMed ID: 29925
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Blood hormone levels in threatened abortion].
    Fedorova MV; Bespalova VA; Tereshchenko LI; Khokhlova ID
    Akush Ginekol (Mosk); 1984 Dec; (12):31-3. PubMed ID: 6241799
    [No Abstract]   [Full Text] [Related]  

  • 96. Plasma hormone profile of threatened abortion and its prognosis.
    Miyakawa I; Ikeda I; Maeyama M
    Int J Gynaecol Obstet; 1977; 15(1):12-6. PubMed ID: 562785
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Treatment of threatened early abortion (6th-16th week of pregnancy) of Th 1165a (Partusisten)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1976; 98(13):792-4. PubMed ID: 8935
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of micronized progesterone on fetal-placental volume in first-trimester threatened abortion.
    Turgal M; Aydin E; Ozyuncu O
    J Clin Ultrasound; 2017 Jan; 45(1):14-19. PubMed ID: 27480401
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Serum oxytocin and oxytocinase activities in women during pregnancy].
    Gordina VZ
    Akush Ginekol (Mosk); 1991 Apr; (4):11-3. PubMed ID: 1862862
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [The radial immunodiffusion method used in determination of serum HPL].
    Weisz G; Basile F; Bini P; Giaretto G
    Minerva Ginecol; 1978 Dec; 30(12):1085-8. PubMed ID: 105329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.